The corticobasal syndrome–Alzheimer’s disease conundrum

References

• Boeve BF. Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis. Assoc. Disord.21(4), S31–S38 (2007).
   PubMed Web of Science ®Google Scholar
• Hu WT, Rippon GW, Boeve BF et al. Alzheimer’s disease and corticobasal degeneration presenting as corticobasal syndrome. Mov. Disord.24(9), 1375–1379 (2009).
   PubMedGoogle Scholar
• Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life? Mov. Disord.24(11), 1593–1599 (2009).
   PubMed Web of Science ®Google Scholar
• Josephs KA, Petersen RC, Knopman DS et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology66(1), 41–48 (2006).
   PubMed Web of Science ®Google Scholar
• Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology48(4), 959–969 (1997).
   PubMed Web of Science ®Google Scholar
• Josephs KA, Holton JL, Rossor MN et al. Neurofilament inclusion body disease: a new proteinopathy? Brain126(Pt 10), 2291–2303 (2003).
   PubMed Web of Science ®Google Scholar
• Boeve BF, Maraganore DM, Parisi JE et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology53(4), 795–800 (1999).
   PubMed Web of Science ®Google Scholar
• Masellis M, Momeni P, Meschino W et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain129(Pt 11), 3115–3123 (2006).
   PubMed Web of Science ®Google Scholar
• Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov. Disord.14(4), 674–680 (1999).
   PubMed Web of Science ®Google Scholar
• Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology53(9), 1969–1974 (1999).
   PubMed Web of Science ®Google Scholar
• Alladi S, Xuereb J, Bak T et al. Focal cortical presentations of Alzheimer’s disease. Brain130(Pt 10), 2636–2645 (2007).
   PubMed Web of Science ®Google Scholar
• Doran M, du Plessis DG, Enevoldson TP, Fletcher NA, Ghadiali E, Larner AJ. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J. Neurol. Sci.216(1), 127–134 (2003).
   PubMed Web of Science ®Google Scholar
• Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann. Neurol.54(Suppl. 5), S15–S19 (2003).
   PubMed Web of Science ®Google Scholar
• Hassan A, Whitwell JL, Boeve BF et al. Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat. Disord.16(3), 208–214 (2010).
   PubMedGoogle Scholar
• Doody RS, Jankovic J. The alien hand and related signs. J. Neurol. Neurosurg. Psychiatry55(9), 806–810 (1992).
   PubMed Web of Science ®Google Scholar
• Gottlieb D, Robb K, Day B. Mirror movements in the alien hand syndrome. Case report. Am. J. Phys. Med. Rehabil.71(5), 297–300 (1992).
   PubMed Web of Science ®Google Scholar
• Josephs KA, Duffy JR, Strand EA et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain129(Pt 6), 1385–1398 (2006).
   PubMed Web of Science ®Google Scholar
• Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch. Neurol.18(1), 20–33 (1968).
   PubMedGoogle Scholar
• Yu CE, Bird TD, Bekris LM et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch. Neurol.67(2), 161–170 (2010).
   PubMed Web of Science ®Google Scholar
• Kelley BJ, Haidar W, Boeve BF et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol. Aging30(5), 739–751 (2009).
   PubMed Web of Science ®Google Scholar
• Josephs KA, Hodges JR, Snowden JS et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol.122(2), 137–153 (2011).
   PubMed Web of Science ®Google Scholar
• Ling H, O’Sullivan SS, Holton JL et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain133(Pt 7), 2045–2057 (2010).
   PubMed Web of Science ®Google Scholar
• Ball JA, Lantos PL, Jackson M, Marsden CD, Scadding JW, Rossor MN. Alien hand sign in association with Alzheimer’s histopathology. J. Neurol. Neurosurg. Psychiatry56(9), 1020–1023 (1993).
   PubMed Web of Science ®Google Scholar
• Chand P, Grafman J, Dickson D, Ishizawa K, Litvan I. Alzheimer’s disease presenting as corticobasal syndrome. Mov. Disord.21(11), 2018–2022 (2006).
   PubMedGoogle Scholar
• Eberhard DA, Lopes MB, Trugman JM, Brashear HR. Alzheimer’s disease in a case of cortical basal ganglionic degeneration with severe dementia. J. Neurol. Neurosurg. Psychiatry60(1), 109–110 (1996).
   PubMedGoogle Scholar
• Golaz J, Bouras C, Hof PR. Motor cortex involvement in presenile dementia: report of a case. J. Geriatr. Psychiatry Neurol.5(2), 85–92 (1992).
   PubMedGoogle Scholar
• Horoupian DS, Wasserstein PH. Alzheimer’s disease pathology in motor cortex in dementia with lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol.98(3), 317–322 (1999).
   PubMed Web of Science ®Google Scholar
• Imamura A, Wszolek ZK, Lucas JA, Dickson DW. Corticobasal syndrome with Alzheimer’s disease pathology. Mov. Disord.24(1), 152–153 (2009).
   PubMedGoogle Scholar
• Jagust WJ, Davies P, Tiller-Borcich JK, Reed BR. Focal Alzheimer’s disease. Neurology40(1), 14–19 (1990).
   PubMed Web of Science ®Google Scholar
• Kaida K, Takeda K, Nagata N, Kamakura K. Alzheimer’s disease with asymmetric parietal lobe atrophy: a case report. J. Neurol. Sci.160(1), 96–99 (1998).
   PubMedGoogle Scholar
• Lleo A, Rey MJ, Castellvi M, Ferrer I, Blesa R. Asymmetric myoclonic parietal syndrome in a patient with Alzheimer’s disease mimicking corticobasal degeneration. Neurologia17(4), 223–226 (2002).
   PubMedGoogle Scholar
• Osako M, Mochizuki Y, Kugio Y, Mizutani T, Hayashi H. [Autopsy case of atypical type of alzheimer’s disease clinically diagnosed as corticobasal degeneration]. Rinsho Shinkeigaku47(9), 581–584 (2007).
   PubMedGoogle Scholar
• Pogacar S, Williams RS. Alzheimer’s disease presenting as slowly progressive aphasia. RI Med. J.67(4), 181–185 (1984).
   PubMedGoogle Scholar
• Ceccaldi M, Poncet M, Gambarelli D, Guinot H, Bille J. [Progressive severity of left unilateral apraxia in 2 cases of Alzheimer disease]. Rev. Neurol. (Paris)151(4), 240–246 (1995).
   PubMed Web of Science ®Google Scholar
• Okazaki K, Fu YJ, Nishihira Y et al. Alzheimer’s disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration. Neuropathology30(2), 140–148 (2010).
   PubMedGoogle Scholar
• Litvan I, Agid Y, Goetz C et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology48(1), 119–125 (1997).
   PubMed Web of Science ®Google Scholar
• Dickson DW, Bergeron C, Chin SS et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J. Neuropathol. Exp. Neurol.61(11), 935–946 (2002).
   PubMed Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34(7), 939–944 (1984).
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol.82(4), 239–259 (1991).
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Evolution of the neuropathology of Alzheimer’s disease. Acta Neurol. Scand. Suppl.165, 3–12 (1996).
   PubMedGoogle Scholar
• Kramer JH, Miller BL. Alzheimer’s disease and its focal variants. Semin. Neurol.20(4), 447–454 (2000).
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Weigand SD, Shiung MM et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer’s disease. Brain130(Pt 3), 708–719 (2007).
   PubMedGoogle Scholar
• Josephs KA, Whitwell JL, Dickson DW et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol. Aging29(2), 280–289 (2008).
   PubMed Web of Science ®Google Scholar
• Katzman R KC. The Epidemiology of Dementia and Alzheimer’s Disease. Terry RD, Bick KL (Eds). Raven Press, New York, NY, USA (1994).
   Google Scholar
• Weiner MF, Vega G, Risser RC et al. Apolipoprotein E ε4, other risk factors, and course of Alzheimer’s disease. Biol. Psychiatry45(5), 633–638 (1999).
   PubMedGoogle Scholar
• van Duijn CM, Stijnen T, Hofman A. Risk factors for Alzheimer’s disease: overview of the EURODEM collaborative re-analysis of case–control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol.20(Suppl. 2), S4–S12 (1991).
   PubMed Web of Science ®Google Scholar
• Hutton M, Lendon CL, Rizzu P et al. Association of missense and 5´-splice-site mutations in tau with the inherited dementia FTDP-17. Nature393(6686), 702–705 (1998).
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA95(13), 7737–7741 (1998).
   PubMed Web of Science ®Google Scholar
• Scaravilli T, Tolosa E, Ferrer I. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov. Disord.20(Suppl. 12), S21–S28 (2005).
   PubMedGoogle Scholar
• Rabinovici GD, Furst AJ, Alkalay A et al. Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden. Brain133(Pt 2), 512–528 (2010).
   PubMed Web of Science ®Google Scholar
• Licht EA, McMurtray AM, Saul RE, Mendez MF. Cognitive differences between early- and late-onset Alzheimer’s disease. Am. J. Alzheimers Dis. Other Demen.22(3), 218–222 (2007).
   PubMedGoogle Scholar
• Green EK, Thaker U, McDonagh AM et al. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer’s disease, nor does it influence the extent of tau pathology in the brain. Neurosci. Lett.324(2), 113–116 (2002).
   PubMed Web of Science ®Google Scholar
• Houlden H, Baker M, Morris HR et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology56(12), 1702–1706 (2001).
   PubMed Web of Science ®Google Scholar
• Bird T. Alzheimer disease overview. In: Gene Reviews. Pagon RA, Bird TE, Dolan CR et al. (Eds). University of Washington, Seattle, WA, USA (2003).
   Google Scholar
• Josephs KA, Whitwell JL, Boeve BF et al. Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer’s disease. Mov. Disord.25(9), 1246–1252 (2010).
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Jack CR Jr, Boeve BF et al. Imaging correlates of pathology in corticobasal syndrome. Neurology75(21), 1879–1887 (2010).
   PubMed Web of Science ®Google Scholar
• Borroni B, Premi E, Agosti C et al. CSF Alzheimer’s disease-like pattern in corticobasal syndrome: evidence for a distinct disorder. J. Neurol. Neurosurg. Psychiatry82(8), 834–838 (2011).
   PubMedGoogle Scholar
• Pillon B, Blin J, Vidailhet M et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology45(8), 1477–1483 (1995).
   PubMed Web of Science ®Google Scholar
• Soliveri P, Monza D, Paridi D et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology53(3), 502–507 (1999).
   PubMed Web of Science ®Google Scholar
• Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase11(4), 268–273 (2005).
   PubMed Web of Science ®Google Scholar
• Graham NL, Bak T, Patterson K, Hodges JR. Language function and dysfunction in corticobasal degeneration. Neurology61(4), 493–499 (2003).
   PubMed Web of Science ®Google Scholar
• Cummings JL. Biomarkers in Alzheimer’s disease – perspectives for the future. US Neurology6(1), 23–27 (2010).
   Google Scholar
• Blennow K, Hampel H. CSF markers for incipient Alzheimer’s disease. Lancet Neurol.2(10), 605–613 (2003).
   PubMed Web of Science ®Google Scholar
• Shaw LM, Vanderstichele H, Knapik-Czajka M et al. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann. Neurol.65(4), 403–413 (2009).
   PubMed Web of Science ®Google Scholar
• Tapiola T, Alafuzoff I, Herukka SK et al. Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol.66(3), 382–389 (2009).
   PubMedGoogle Scholar
• Koyama M, Yagishita A, Nakata Y, Hayashi M, Bandoh M, Mizutani T. Imaging of corticobasal degeneration syndrome. Neuroradiology49(11), 905–912 (2007).
   PubMed Web of Science ®Google Scholar
• Schrag A, Good CD, Miszkiel K et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology54(3), 697–702 (2000).
   PubMed Web of Science ®Google Scholar
• Josephs KA, Tang-Wai DF, Edland SD et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch. Neurol.61(12), 1881–1884 (2004).
   PubMedGoogle Scholar
• Jones BF, Barnes J, Uylings HB et al. Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cereb. Cortex16(12), 1701–1708 (2006).
   PubMed Web of Science ®Google Scholar
• Rusinek H, de Leon MJ, George AE et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology178(1), 109–114 (1991).
   PubMedGoogle Scholar
• Whitwell JL, Jack CR Jr, Przybelski SA et al. Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol. Aging32(9), 1531–1541 (2009).
   PubMedGoogle Scholar
• Whitwell JL, Jack CR Jr, Parisi JE et al. Rates of cerebral atrophy differ in different degenerative pathologies. Brain130(Pt 4), 1148–1158 (2007).
   PubMed Web of Science ®Google Scholar
• Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc. Natl Acad. Sci. USA101(13), 4637–4642 (2004).
   PubMed Web of Science ®Google Scholar
• Wu X, Li R, Fleisher AS et al. Altered default mode network connectivity in alzheimer’s disease – a resting functional MRI and bayesian network study. Hum. Brain Mapp. DOI: 10.1002/hbm.21153 (2011) (Epub ahead of print).
   Google Scholar
• Zhang L, Murata Y, Ishida R, Saitoh Y, Mizusawa H, Shibuya H. Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET. Nucl. Med. Commun.22(7), 767–772 (2001).
   PubMedGoogle Scholar
• Bonte FJ, Harris TS, Roney CA, Hynan LS. Differential diagnosis between Alzheimer’s and frontotemporal disease by the posterior cingulate sign. J. Nucl. Med.45(5), 771–774 (2004).
   PubMed Web of Science ®Google Scholar
• McNeill R, Sare GM, Manoharan M et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry78(4), 350–355 (2007).
   PubMedGoogle Scholar
• Juh R, Pae CU, Kim TS, Lee CU, Choe B, Suh T. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci. Lett.383(1–2), 22–27 (2005).
   PubMed Web of Science ®Google Scholar
• Peigneux P, Salmon E, Garraux G et al. Neural and cognitive bases of upper limb apraxia in corticobasal degeneration. Neurology57(7), 1259–1268 (2001).
   PubMed Web of Science ®Google Scholar
• Teune LK, Bartels AL, de Jong BM et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov. Disord.25(14), 2395–2404 (2010).
   PubMed Web of Science ®Google Scholar
• Quigley H, Colloby SJ, O’Brien JT. PET imaging of brain amyloid in dementia: a review. Int. J. Geriatr. Psychiatry26(10), 991–999 (2011).
   PubMed Web of Science ®Google Scholar
• Balasa M, Gelpi E, Antonell A et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology76(20), 1720–1725 (2011).
   PubMed Web of Science ®Google Scholar
• Crystal HA, Horoupian DS, Katzman R, Jotkowitz S. Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome. Ann. Neurol.12(2), 186–188 (1982).
   PubMed Web of Science ®Google Scholar
• Libon DJ, Xie SX, Moore P et al. Patterns of neuropsychological impairment in frontotemporal dementia. Neurology68(5), 369–375 (2007).
   PubMed Web of Science ®Google Scholar
• Lee SE, Rabinovici GD, Mayo MC et al. Clinicopathological correlations in corticobasal degeneration. Ann. Neurol.70(2), 327–340 (2011).
   PubMed Web of Science ®Google Scholar